Home > Healthcare > Medical Devices > Surgical Devices > Embolic Protection Devices Market

Embolic Protection Devices Market Size

Report ID: GMI2417
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Embolic Protection Devices Market Size

Embolic Protection Devices Market was worth USD 1.4 billion in 2022. Driven by the increasing number of cardiovascular diseases (CVDs) globally, the industry is estimated to witness over 8.5% CAGR between 2023 and 2032. According to the WHO, CVDs are the leading cause of death globally, accounting for 17.9 million deaths in 2022.

To get key market trends

Download Free Sample

The growing number of patients suffering from cardiac problems is fueling the need for percutaneous coronary interventions and the subsequent rise in demand for interventional cardiology & peripheral vascular devices. As per CDC, coronary artery disease is the most prevalent kind of heart disease in the U.S. The growing prevalence of CAD is contributing to rising product demand. Additionally, embolic protection devices provide the most effective, evidence-based method for decreasing significant adverse cardiovascular events and periprocedural myocardial infarction during SVG procedures, which will favor their adoption through 2032.

Embolic Protection Devices Market Report Attributes
Report Attribute	Details
Base Year:	2022
Embolic Protection Devices Market Size in 2022:	USD 1.4 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	8.6%
2032 Value Projection:	USD 3.1 Billion
Historical Data for:	2018 to 2022
No. of Pages:	210
Tables, Charts & Figures:	349
Segments covered:	Product, Application, Material, End-use, & Region
Growth Drivers:	Growing preference for minimally invasive procedures Increasing prevalence of cardiovascular diseases in developed countries Favorable reimbursement scenario in North America Technological advancements in embolic protection devices Growing geriatric population in developing countries
Pitfalls & Challenges:	Availability of alternatives Stringent regulatory framework

Learn more about the key segments shaping this market

Download Free Sample

Embolic Protection Devices Market Growth Drivers & Restraints

The market is poised to gain significant momentum attributed to the favorable reimbursement scenario across American nations and the introduction of new advanced embolic protection devices. However, the availability of cheaper alternatives to embolic protection devices may lead to sluggish growth. Besides, the high cost of these devices may adversely impact product adoption rate since healthcare professionals in developing nations prefer inexpensive medical equipment.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Embolic protection devices market was valued at USD 1.4 billion in 2022 and is poised to exhibit over 8.5% CAGR from 2023 to 2032 owing to the rising prevalence of cardiovascular diseases (CVDs) globally.

The embolic protection devices market from the distal filters segment is estimated to grow at above 8.5% CAGR over 2023-2032 and is expected to generate USD 1.9 billion by 2032 driven by the availability of a wide range of specifications and the surging usage of distal filters.

North America amassed over 35.5% share of the embolic protection devices market in 2022 and is foreseen to be valued at USD 1 billion by 2032 attributed to the rising prevalence of cardiovascular and neurovascular diseases in the region.

Some of the top players engaged in the industry are Transverse Medical, Inc., Abbott Laboratories, Cardinal Health, Allium Medica, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Contego Medical, LLC, Keystone Heart, Medtronic, Metactive Medical, Boston Scientific Corporation, and Innovative Cardiovascular Solutions, LLC.